About
Technology
Issues
FAQ
Links
Official Page
D-1553 (Garsorasib), a Potent and Selective Inhibitor of KRASG12C in Patients With NSCLC: Phase 1 Study Results
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.